- $32.23bn
- $32.68bn
- $4.34bn
Everpure, Illumina gain on S&P 500 inclusion
Brief: Illumina - Enters Credit Agreement On August 13, 2026
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Live Markets: US earnings forecast jumps further after key reports this week
Live Markets: Who's next for the S&P 500? The clock is ticking
U.S. RESEARCH ROUNDUP-Apple, Amazon, Mastercard
Illumina Inc reports results for the quarter ended June 30 - Earnings Summary
Illumina Q2 revenue beats estimates, raises FY revenue outlook
Brief: Illumina Q2 Adjusted EPS USD 1.31 Vs. IBES Estimate USD 1.23
Danaher's revenue outlook cut, biotech miss overshadow profit forecast lift (updated)
Danaher's revenue outlook cut, biotech miss overshadow profit forecast raise
Danaher falls after cutting annual revenue growth forecast
Roche takes aim at Illumina's dominance with new gene sequencing machine (updated)
Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip
U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
U.S. STOCKS ON THE MOVE-Illumina, Cullinan, BorgWarner
Illumina rises after J.P. Morgan upgrades to 'overweight'
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific